Chemistry:Abafungin

From HandWiki
Short description: Chemical compound
Abafungin
Structural formula of abafungin
Space-filling model of the abafungin molecule
Clinical data
Trade namesAbasol
Routes of
administration
Topical (cream)
ATC code
  • none
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
Chemical and physical data
FormulaC21H22N4OS
Molar mass378.49 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Abafungin (INN) is a broad-spectrum antifungal agent with a novel mechanism of action for the treatment of dermatomycoses.

Abasol is a topical cream formulation of abafungin by York Pharma.[1]

History

Abafungin was first synthesized at Bayer AG, Leverkusen, Germany. A study of H2-antagonists related to famotidine, resulted in the discovery of its antifungal properties.[2]

Its development seems to have been discontinued in 2009.[3]

Mechanism of action

Unlike imidazole- and triazole-class antifungals, abafungin directly impairs the fungal cell membrane.[2]

In addition, abafungin inhibits the enzyme sterol 24-C-methyltransferase, modifying the composition of the fungal membrane.[4]

Abafungin has antibiotic activity against gram-positive bacteria as well as sporicidal activity.[5]

References

  1. "Regulatory Update – Abasol". York Pharma. http://www.yorkpharma.com/media/YRK-Update_Abasol_061002-FN.pdf. 
  2. 2.0 2.1 "Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi". Chemotherapy 54 (4): 245–59. August 2008. doi:10.1159/000142334. PMID 18587237. 
  3. "Abafungin". AdisInsight. https://adisinsight.springer.com/drugs/800022887. Retrieved 5 May 2021. 
  4. "ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis". Kidney International 48 (6): 1778–91. December 1995. doi:10.1038/ki.1995.476. PMID 8587237. 
  5. Ginter-Hanselmayer, Gabriele (March 2009). Arbeitsunterlagen zur 42. wissenschaftlichen Fortbildungsveranstaltung für Apothekerinnen und Apotheker: Infektionskrankheiten. Österreichische Apothekerkammer. p. 103. 

External links